Arkolith/Insider Trading/TMDX/Form 4

Hassanein Waleed H

President & CEO, DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Oct 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2024Sell(S)300$135.04$41K62K
Oct 15, 2024Sell(S)1K$134.23$161K62K
Oct 15, 2024Option exercise(M)9K$13.28$115K70K
Oct 15, 2024Sell(S)4K$131.91$476K67K
Oct 15, 2024Sell(S)4K$132.82$467K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2024Option exercise(M)9K—$096K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-115332) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML